QS Investors LLC decreased its stake in shares of ICU Medical, Incorporated (NASDAQ:ICUI) by 3.1% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 28,754 shares of the medical instruments supplier’s stock after selling 911 shares during the period. QS Investors LLC owned 0.14% of ICU Medical worth $6,211,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently modified their holdings of the stock. BlackRock Inc. lifted its holdings in ICU Medical by 3.4% during the 4th quarter. BlackRock Inc. now owns 1,879,874 shares of the medical instruments supplier’s stock worth $406,052,000 after purchasing an additional 62,605 shares in the last quarter. Janus Henderson Group PLC lifted its holdings in ICU Medical by 17.6% during the 3rd quarter. Janus Henderson Group PLC now owns 1,684,094 shares of the medical instruments supplier’s stock worth $312,989,000 after purchasing an additional 251,793 shares in the last quarter. Wells Fargo & Company MN lifted its holdings in ICU Medical by 0.9% during the 3rd quarter. Wells Fargo & Company MN now owns 560,756 shares of the medical instruments supplier’s stock worth $104,217,000 after purchasing an additional 5,044 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in ICU Medical by 3.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 432,281 shares of the medical instruments supplier’s stock worth $80,122,000 after purchasing an additional 14,537 shares in the last quarter. Finally, Eagle Asset Management Inc. lifted its holdings in ICU Medical by 2.3% during the 3rd quarter. Eagle Asset Management Inc. now owns 194,839 shares of the medical instruments supplier’s stock worth $36,629,000 after purchasing an additional 4,330 shares in the last quarter. 77.25% of the stock is currently owned by institutional investors and hedge funds.
In other ICU Medical news, CFO Scott E. Lamb sold 23,624 shares of the firm’s stock in a transaction dated Thursday, January 4th. The stock was sold at an average price of $220.00, for a total value of $5,197,280.00. Following the sale, the chief financial officer now owns 29,723 shares of the company’s stock, valued at approximately $6,539,060. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Robert S. Swinney sold 724 shares of the firm’s stock in a transaction dated Friday, January 19th. The shares were sold at an average price of $235.00, for a total value of $170,140.00. Following the completion of the sale, the director now directly owns 14,830 shares in the company, valued at approximately $3,485,050. The disclosure for this sale can be found here. Company insiders own 13.60% of the company’s stock.
Shares of ICU Medical, Incorporated (NASDAQ ICUI) opened at $255.35 on Wednesday. ICU Medical, Incorporated has a 1-year low of $144.25 and a 1-year high of $265.27. The firm has a market capitalization of $5,244.01, a PE ratio of 76.68, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42. The company has a quick ratio of 3.01, a current ratio of 4.65 and a debt-to-equity ratio of 0.07.
ICU Medical (NASDAQ:ICUI) last released its quarterly earnings results on Thursday, March 1st. The medical instruments supplier reported $2.98 earnings per share for the quarter, beating the consensus estimate of $1.04 by $1.94. ICU Medical had a return on equity of 8.54% and a net margin of 5.31%. The firm had revenue of $370.12 million for the quarter, compared to analysts’ expectations of $332.91 million. During the same quarter last year, the firm posted $1.20 EPS. The company’s revenue was up 286.8% compared to the same quarter last year. equities research analysts forecast that ICU Medical, Incorporated will post 6.29 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: “QS Investors LLC Sells 911 Shares of ICU Medical, Incorporated (ICUI)” was reported by American Banking News and is the property of of American Banking News. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at https://www.americanbankingnews.com/2018/03/14/qs-investors-llc-sells-911-shares-of-icu-medical-incorporated-icui.html.
ICU Medical Company Profile
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.